Table 2. ncRNAs involved in the regulation of adaptive immune cells.
NcRNA | Expression in HCC | Related immune cell | Target molecules/pathway | Function in TIME | Impact on HCC | Reference |
---|---|---|---|---|---|---|
lncRNA NEAT1 | Upregulated | CD8+ T cells | miR-155/Tim-3 | Induce CD8+ T cells apoptosis and dampen its cytolysis activity against HCC cells | Promote immune evasion and tumor progression | 65 |
lncRNA lnc-Tim3 | Upregulated | CD8+ T cells | Tim-3/Bat3/Lck/ZAP70/AP-1/NF-AT1 and Bat3/p300/p53/RelA | Stimulate CD8+ T-cell exhaustion | Promote immunosuppression and tumor growth | 66 |
circRNA circMET | Upregulated | CD8+ T lymphocytes | miR-30-5p/Snail/DPP4/CXCL10 | Stimulate CD8+ lymphocyte infiltration | Enhance immunosuppression | 67 |
microRNA-132 | Upregulated | Th17 | SNIP1 | Promote Th17 differentiation and function | Promote HCC cell migration and EMT | 68 |
microRNA-34a | Downregulated | Tregs | CCL22 | Suppress Treg recruitment | Enhance immune surveillance, suppress tumor growth, and metastasis | 69 |
lncRNA EGFR | Upregulated | Tregs | EGFR/AP-1/NF-AT1 | Stimulate Treg differentiation, inhibit CTL activity | Promote immunosuppression and HCC growth | 70 |
circRNA circGSE1 | Upregulated | Tregs | miR-324-5p/TGFBR1/Smad3/FOXP3 axis | Induce the expansion of Tregs | Promote immune escape, enhance tumor growth and metastasis | 71 |
lncRNA FENDRR | Downregulated | Tregs | miR-423-5p/GADD45B | Inhibit Treg infiltration | Suppress immune escape and tumor growth | 72 |
lncRNA LINC00261 | Downregulated | B cells | miR105-5p/SELL | Promote B-cell dysfunction | Promote HCC progression | 73 |
HCC, hepatocellular carcinoma; NA, not available; ncRNA, noncoding RNA; Th, T-helper cell; TIME, tumor immune microenvironment; Treg, regulatory T cells.